Vaccine-associated paralytic polio in India.
Vaccine-associated paralytic polio in India.
复制标题
印度与疫苗相关的麻痹性脊髓灰质炎。
DOI：
10.1590/s0042-96862002001100017
复制
发表时间：
2002
影响因子：
11.1
通讯作者：
T. John
中科院分区：
文献类型：
--
作者：
T. John
鉴于印度疫苗相关麻痹性脊髓灰质炎（VAPP）的风险增加，技术协商小组将不得不修订其对VAPP全球负担的估计，并探讨用灭活脊髓灰质炎疫苗取代口服脊髓灰质炎疫苗（OPV）的可能性，以避免VAPP。从科学和伦理的角度来看，根除必须导致完全不存在由任何野生脊髓灰质炎病毒或与疫苗有关的脊髓灰质炎病毒引起的脊髓灰质炎。(摘录)
In light of the increased risk of vaccine-associated paralytic poliomyelitis (VAPP) in India the Technical Consultative Group will have to revise its estimate of the global burden of VAPP and explore the possibility of replacing oral polio vaccine (OPV) with inactivated polio vaccine in order to avoid VAPP. In scientific and ethical terms eradication must result in the total absence of poliomyelitis due to any polioviruses wild or vaccine-related. (excerpt)